DNA-mediated Adjuvant Immunotherapy Extends Survival in Two Different Mouse Models of Myeloid Malignancies

Oncotarget - United States
doi 10.18632/oncotarget.5572
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Mouse Models for Cancer Immunotherapy Research

Cancer Discovery
Oncology
2018English

Immunotherapy in Genitourinary Malignancies

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Reference Gene and Protein Expression Levels in Two Different NAFLD Mouse Models

Gastroenterology Research and Practice
HepatologyGastroenterology
2020English

Advances in Immunotherapy for Hematological Malignancies

Journal of Nihon University Medical Association
2016English

Ramucirumab Extends Gastric Cancer Survival

Cancer Discovery
Oncology
2014English

Role of the Microenvironment in Myeloid Malignancies

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2017English

Absence of Subcerebral Projection Neurons Delays Disease Onset and Extends Survival in a Mouse Model of ALS

2019English

Improved Resection and Prolonged Overall Survival With PD-1-IRDye800CW Fluorescence Probe-Guided Surgery and PD-1 Adjuvant Immunotherapy in 4T1 Mouse Model

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2017English

Utilizing the Adjuvant Properties of CD1d-dependent NK T Cells in T Cell–mediated Immunotherapy

Journal of Clinical Investigation
Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy